Sjs Investment Consulting Inc. Harrow Health, Inc. Transaction History
Sjs Investment Consulting Inc.
- $647 Million
- Q3 2025
A detailed history of Sjs Investment Consulting Inc. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 6,073 shares of HROW stock, worth $220,875. This represents 0.04% of its overall portfolio holdings.
Number of Shares
6,073
Previous 6,073
-0.0%
Holding current value
$220,875
Previous $185,000
54.59%
% of portfolio
0.04%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding HROW
# of Institutions
192Shares Held
21.9MCall Options Held
390KPut Options Held
413K-
Opaleye Management Inc. Boston, MA3.91MShares$142 Million28.52% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$78.1 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.95MShares$70.8 Million6.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$68 Million0.0% of portfolio
-
Braidwell LP Stamford, CT872KShares$31.7 Million1.63% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $985M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...